e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Experimental pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determination of cell-derived microparticles in patients with pulmonary hypertension and connective-tissue diseases using flow cytometry
X. Kqiku, G. Kovacs, E. Rohde, D. Strunk, H. Olschewski (Graz, Salzburg, Austria)
Source:
Annual Congress 2011 - Experimental pulmonary hypertension
Session:
Experimental pulmonary hypertension
Session type:
Poster Discussion
Number:
3345
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Kqiku, G. Kovacs, E. Rohde, D. Strunk, H. Olschewski (Graz, Salzburg, Austria). Determination of cell-derived microparticles in patients with pulmonary hypertension and connective-tissue diseases using flow cytometry. Eur Respir J 2011; 38: Suppl. 55, 3345
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
The flow cytometric immunophenotyping of peripheral blood in Chronic obstructive pulmonary disease patients
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD
Source: Eur Respir J 2004; 23: 532-537
Year: 2004
Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006
Pulmonary artery blood flow dynamics in patients with chronic thromboembolic pulmonary hypertension; Analysis by computational fluid dynamics
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Cellular microparticles in the pathogenesis of pulmonary hypertension
Source: Eur Respir J 2013; 42: 272-279
Year: 2013
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017
Year: 2018
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Determination of pulmonary hypertension degree in patients with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2010; 36: 1302-1314
Year: 2010
LSC - 2020 - Comparison of metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Comparison of arterial and venous blood gases analysis in patients with exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 326s
Year: 2007
Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012
Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept